On 23 February, the Dutch Medicines Evaluation Board organized its i-day. The MEB informed the audience that they had emerged from a period of technological struggles to being able to start implementing their i-vision. I-vision deliberately moves away from the “e-“prefix to the “i-“ prefix to emphasize that their endeavors in the information-area go beyond simply implementing new electronic systems into restructuring the way they process information as one of the major European NCAs.
MEB clearly presented how new forms of processing data like IDMP and CESSP help them to move their resources from administrative activities to activities that add value for society, in particular the patient. They further emphasized that cooperation in Europe is essential for realizing the potential of new technologies especially now the case of BREXIT means that the large amount of work shouldered by the MHRA will have to be redistributed across the remaining EEA countries. Nonetheless, the MEB feels that this need for cooperation should not be an impediment for them to realize their own i-vision and the solutions it could bring to issues in the Dutch territory. Specifically, the MEB presented on their plans and activities with regard to the long awaited but never quite realized digital unlocking of patient information in forms that will serve each patient in their individual needs instead of remaining with the current one size fits nobody.
Do you also want to develop a new vision on your information? We can help.